Xolair 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FNMTU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,884
Award facts
- Contract value 100% obligated
- $14,883.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,883.84 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 mL syringes. The contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. This delivery order falls under DMS's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and effective through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the Defense Logistics Agency covering branded and generic prescription drugs, biologics, and medical consumables. The company's expertise in pharmaceutical distribution to military health facilities positions it to reliably deliver Xolair, a biologic medication commonly used in allergy and asthma treatment, to support Defense Department medical supply requirements. This delivery order represents one component of the agency's ongoing procurement strategy to maintain adequate pharmaceutical inventory across military healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FNMTU?
SPE2DB25FNMTU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FNMTU worth?
The government has obligated $14,884 on SPE2DB25FNMTU.
Is contract SPE2DB25FNMTU an order under another contract?
Yes. SPE2DB25FNMTU is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMTU competed?
The extent of competition for SPE2DB25FNMTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award